CSS
ENTX icon

Cubist Systematic Strategies’s Entera Bio ENTX Stock Holding History

Cubist Systematic Strategies’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.97K Buy
4,673
+3,858
+473% +$7.38K ﹤0.01% 2926
2025
Q2 		$1.55K Sell
815
-745
-48% -$1.47K ﹤0.01% 2875
2025
Q1 		$2.65K Buy
+1,560
New +$3.39K ﹤0.01% 2774

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Cubist Systematic Strategies's ENTX Position: Q3 2025 in Review

Cubist Systematic Strategies increased its Entera Bio (ENTX) stake by 473% in Q3 2025, buying an estimated $7.38K and bringing the position to 4,673 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #2926.

Cubist Systematic Strategies first reported a position in ENTX in Q1 2025 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold ENTX as of Q3 2025.

  • Cubist Systematic Strategies held 4,673 shares of Entera Bio worth $8.97K as of Q3 2025.
  • Cubist Systematic Strategies bought 3,858 Entera Bio shares in Q3 2025, an estimated $7.38K.
  • Entera Bio made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2926 holding.
  • Cubist Systematic Strategies first reported a position in Entera Bio in Q1 2025 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Entera Bio as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.